Curative Biosciences Stock Current Valuation
| CBDX Stock | USD 0.0001 0.00 0.00% |
Valuation analysis of Curative Biosciences helps investors to measure Curative Biosciences' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Curative Biosciences' price fluctuation is very steady at this time. Calculation of the real value of Curative Biosciences is based on 3 months time horizon. Increasing Curative Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Curative Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Curative Pink Sheet. However, Curative Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Curative Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Curative Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Curative Biosciences helps investors to forecast how Curative pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Curative Biosciences more accurately as focusing exclusively on Curative Biosciences' fundamentals will not take into account other important factors: Curative Biosciences Company Current Valuation Analysis
Curative Biosciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Curative Biosciences Current Valuation | 9.68 M |
Most of Curative Biosciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Curative Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Curative Biosciences has a Current Valuation of 9.68 M. This is 99.93% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 99.94% higher than that of the company.
Curative Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Curative Biosciences' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Curative Biosciences could also be used in its relative valuation, which is a method of valuing Curative Biosciences by comparing valuation metrics of similar companies.Curative Biosciences is currently under evaluation in current valuation category among its peers.
Curative Fundamentals
| Return On Asset | -38.44 | |||
| Current Valuation | 9.68 M | |||
| Shares Outstanding | 31.57 M | |||
| Shares Owned By Insiders | 76.24 % | |||
| EBITDA | (50.35 K) | |||
| Net Income | (53.2 K) | |||
| Cash And Equivalents | 982 | |||
| Total Debt | 156.45 K | |||
| Book Value Per Share | (0.04) X | |||
| Cash Flow From Operations | (12.8 K) | |||
| Earnings Per Share | (0.03) X | |||
| Beta | 8.19 | |||
| Market Capitalization | 10.56 M | |||
| Total Asset | 2.27 K | |||
| Z Score | -32.4 | |||
| Net Asset | 2.27 K |
About Curative Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Curative Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Curative Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Curative Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Curative Pink Sheet Analysis
When running Curative Biosciences' price analysis, check to measure Curative Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biosciences is operating at the current time. Most of Curative Biosciences' value examination focuses on studying past and present price action to predict the probability of Curative Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biosciences' price. Additionally, you may evaluate how the addition of Curative Biosciences to your portfolios can decrease your overall portfolio volatility.